17.83
Assertio Holdings Inc (ASRT) 最新ニュース
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Research Analysts Set Expectations for Assertio Q1 Earnings - MarketBeat
Assertio outlines $110M–$125M 2026 revenue target with Rolvedon at the core while shifting business development approach - MSN
Assertio (NASDAQ:ASRT) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
H.C. Wainwright reiterates Assertio stock rating on strong revenue - Investing.com UK
H.C. Wainwright reiterates Assertio stock rating on strong revenue By Investing.com - Investing.com South Africa
Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2025 Earnings Call Transcript - Insider Monkey
Assertio Holdings 2025 Annual Report: Business Overview, Strategy, Risks, and Financial Performance - Minichart
Assertio Holdings Inc (ASRT) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Assertio Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Assertio Q4 2025 misses EPS forecast By Investing.com - Investing.com India
Assertio Holdings 2025 Results & New Strategy: Rolvedon Focus, End of Acquisition-Led GrowthNews and Statistics - IndexBox
Earnings Call Summary | Assertio(ASRT.US) Q4 2025 Earnings Conference - 富途牛牛
Earnings call transcript: Assertio Q4 2025 misses EPS forecast - Investing.com
Assertio Q4 Earnings Call Highlights - MarketBeat
Assertio (ASRT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Assertio (ASRT) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
Assertio Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Assertio Holdings 2025 10-K: Revenues $118.7M, EPS loss $(4.74) - TradingView
Assertio Holdings Q4 2025 Results: $11.9M Loss, Revenue $13.5MNews and Statistics - IndexBox
Assertio Q4 Swings to Adjusted Loss, Revenue Declines - marketscreener.com
Assertio (NASDAQ: ASRT) 2025 report centers on ROLVEDON, divestiture and reverse split - Stock Titan
Assertio: Q4 Earnings Snapshot - kens5.com
Assertio (NASDAQ:ASRT) Posts Quarterly Earnings Results, Beats Estimates By $1.19 EPS - MarketBeat
Assertio (NASDAQ: ASRT) 2025 results and 2026 earnings guidance - Stock Titan
Assertio Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results - marketscreener.com
BRIEF-Assertio Holdings, Inc. Q4 Adjusted EPS USD -1.06 Vs. IBES Estimate USD -2.71 - TradingView
Assertio Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
ASRT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Assertio Holdings Q4 2025 earnings preview - MSN
Assertio Holdings Inc expected to post a loss of $2.71 a shareEarnings Preview - TradingView
ASRT Stock Price, Quote & Chart | ASSERTIO HOLDINGS INC (NASDAQ:ASRT) - ChartMill
Assertio regains Nasdaq compliance after bid price recovery - MSN
How Assertio Holdings (ASRT) Narrative Is Shifting Around A Steady 37.44 Fair Value Target - Yahoo Finance
Does Assertio Holdings Inc have declining or rising EPSMarket Movement Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know - Finviz
Assertio Holdings to Release 2025 Financial Results on March 16, 2026 - geneonline.com
Assertio Holdings Inc (ASRT) News, Articles, Events & Latest Updates - Stocktwits
Is Assertio (ASRT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
ASRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Assertio (ASRT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Assertio Holdings to Report Q4 and Full Year 2025 Earnings - National Today
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2 - PharmiWeb.com
Assertio Holdings (ASRT) grants CFO RSUs and 21,128 stock options - Stock Titan
Assertio (ASRT) President and COO receives new RSUs and stock options grant - Stock Titan
Assertio (ASRT) EVP awarded new RSUs and stock options - Stock Titan
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - marketscreener.com
ASRT Technical Analysis & ETF Price Forecast - Intellectia AI
ASRT Should I Buy - Intellectia AI
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - The Globe and Mail
Assertio (ASRT) EVP logs RSU vesting and 510-share tax withholding - Stock Titan
Assertio Holdings (ASRT) CFO settles RSUs and withholds shares for taxes - Stock Titan
Assertio Holdings (ASRT) COO settles RSUs and withholds shares for taxes - Stock Titan
Assertio (NASDAQ:ASRT) Shares Up 1.7%Still a Buy? - MarketBeat
FDA Accepts Roche's NDA Seeking Approval for Breast Cancer Drug - Finviz
大文字化:
|
ボリューム (24 時間):